|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,453.00 GBX | -0.90% |
|
-6.77% | -9.72% |
| 03:35am | Molecular Partners Doses First Patients in Phase 2 Study of Biliary Tract Cancer Therapy | MT |
| 02:11am | Keymed Biosciences Expects Return to Profit in H1 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.90% | -6.77% | -6.28% | -16.23% | -9.72% | +19.30% | +22.06% | +49.28% | +175.02% | 263B | |
| +0.35% | -4.87% | +2.42% | +27.80% | +7.63% | +49.87% | +157.34% | +399.69% | +1,341.82% | 1,031B | |
| -2.69% | -6.22% | +4.82% | +3.50% | +19.36% | +59.19% | +54.51% | +46.71% | +100.83% | 595B | |
| -0.27% | -3.41% | +10.16% | +17.12% | +6.84% | +30.97% | +79.48% | +108.32% | +285.52% | 431B | |
| -0.41% | -2.06% | +1.42% | +4.82% | +0.12% | +28.26% | +22.52% | -8.49% | +29.78% | 326B | |
| -0.16% | -2.04% | +1.72% | +3.70% | +11.09% | +28.01% | +43.38% | +44.15% | +51.35% | 277B | |
| +0.70% | +4.01% | +18.80% | +29.47% | +2.38% | -23.20% | -37.87% | +19.83% | +78.94% | 224B | |
| +0.86% | -2.63% | +2.22% | +2.90% | +9.47% | +22.50% | +57.55% | +45.29% | +119.45% | 193B | |
| +1.28% | -3.03% | +5.95% | -5.77% | +7.30% | +20.76% | +70.62% | +92.83% | +51.96% | 164B | |
| +2.35% | +3.20% | -4.54% | -8.72% | -0.32% | +0.85% | -31.66% | -38.09% | -32.50% | 141B | |
| +0.16% | -4.28% | +5.91% | +8.01% | +5.23% | +2.77% | +35.25% | +138.43% | +428.85% | 121B | |
| +3.11% | +2.05% | +4.41% | +1.43% | +8.86% | +26.47% | -5.20% | -12.92% | -22.74% | 120B | |
| -0.09% | -0.38% | +0.70% | -5.76% | -7.89% | -8.43% | -19.08% | -13.29% | +1.36% | 105B | |
| -0.27% | -2.53% | -2.05% | -10.03% | +4.69% | +34.37% | +44.85% | +7.26% | -7.51% | 103B | |
| +1.59% | -1.60% | -3.75% | -15.71% | -12.16% | +6.49% | +85.29% | +78.04% | +467.18% | 72.37B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -0.23% | -6.41% | +31.77% | +16.61% | +28.21% | +72.14% | -5.52% | -6.35% | -48.92% | 53.61B | |
| +4.89% | +6.46% | +20.09% | -0.40% | -3.47% | +0.49% | +21.00% | -4.60% | +258.80% | 55.95B | |
| +1.08% | -0.98% | +6.47% | -5.33% | +10.55% | +22.17% | +24.59% | +43.07% | +19.74% | 51.54B | |
| -0.31% | -0.50% | +7.53% | +1.67% | -4.38% | -0.44% | +13.17% | - | - | 42.68B | |
| Average | +0.55% | -2.05% | +5.67% | +2.58% | +4.41% | +20.66% | +33.28% | +54.95% | +183.27% | 221.71B | |
| Weighted average by Cap. | -0.03% | -3.48% | +4.19% | +9.26% | +6.53% | +31.20% | +63.84% | +128.00% | +410.58% |
- Stock Market
- Stocks
- AZN Stock
- Sector AstraZeneca PLC
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
